AdipoGen Life Sciences Notch signalling research reagents

Wednesday, 31 May, 2017 | Supplied by: Sapphire Bioscience


The Notch signalling pathway regulates many different cell fate decisions in both vertebrate and invertebrate species. Deregulations in Notch signalling components have been associated with various human disorders such as cancer, immune disorders, developmental syndromes, stroke and cognitive symptoms.

AdipoGen Life Sciences brings a comprehensive range of Notch signalling reagents to the market. Products include Notch receptors (Notch 1 and 2), canonical Notch ligands (DLL1, DLL3 and DLL4), non-classical Notch ligands (DLK1 and DLK2), E3 ubiquitin ligases, deubiquitinating enzymes and Notch inhibitors.

The reagents are suitable for scientists requiring tools for cancer, T cell and developmental biology research.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022
Related Products

AdipoGen Life Sciences DYRK inhibitors

Leucettinibs provide research tools and potential leads for further optimisation towards...

GroPep Bioreagents IGF-1 Family Proteins

IGF-1 proteins are available in different sizes, and all GroPep Bioreagents are freeze-dried and...

LSBio PathPlus Neuroscience Antibodies

LSBio PathPlus Neuroscience Antibodies are suitable for immunohistochemistry (IHC) applications...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd